“…Similar findings are reported in the review by Heng et al on genetic variability in acne vulgaris [66]. Somatic mutations and segmental or nonsegmental somatic mosaicism have been involved in a variety of acne-related genetic syndromes such as the Apert syndrome (acrocephalosyndactyly) and nevus comedonicus, associated with FGFR2 (fibroblast growth factor receptor 2) mutations, and the autoinflammatory syndromes PAPA (pyogenic arthritis, pyoderma gangrenosum, acne), PASH (pyoderma gangrenosum, acne, suppurative hidradenitis), PAPASH (pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis), PsAPASH (pustular psoriasis, arthritis, pyoderma gangrenosum, synovitis, acne, suppurative hidradenitis), PASS (pyoderma gangrenosum, acne, suppurative hidradenitis, ankylosing spondylitis) and SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis), with most mutations associated with the IL-1β pathway and matrix metalloproteinases such as MMP 2 and 9 [67]. Somatic mutations and segmental or nonsegmental somatic mosaicism have been involved in a variety of acne-related genetic syndromes such as the Apert syndrome (acrocephalosyndactyly) and nevus comedonicus, associated with FGFR2 (fibroblast growth factor receptor 2) mutations, and the autoinflammatory syndromes PAPA (pyogenic arthritis, pyoderma gangrenosum, acne), PASH (pyoderma gangrenosum, acne, suppurative hidradenitis), PAPASH (pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis), PsAPASH (pustular psoriasis, arthritis, pyoderma gangrenosum, synovitis, acne, suppurative hidradenitis), PASS (pyoderma gangrenosum, acne, suppurative hidradenitis, ankylosing spondylitis) and SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis), with most mutations associated with the IL-1β pathway and matrix metalloproteinases such as MMP 2 and 9 [67].…”